Stem Medicina Regenerativa

Stem Medicina Regenerativa, operating under the brand Stem Corp, is a Brazilian biotechnology company specializing in regenerative medicine and advanced cell therapies. The company maintains a state-of-the-art laboratory for the processing, cryopreservation, and expansion of mesenchymal and hematopoietic stem cells derived from umbilical cord tissue and blood. Stem Medicina Regenerativa is a leader in clinical research in Latin America, conducting trials for complex conditions such as Autism Spectrum Disorder, Cerebral Palsy, and Type 1 Diabetes. Their business model integrates a private biobank with a clinical research center to provide personalized cellular treatments and contribute to the global development of regenerative protocols.